AR056753A1 - Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina - Google Patents

Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina

Info

Publication number
AR056753A1
AR056753A1 ARP060104784A ARP060104784A AR056753A1 AR 056753 A1 AR056753 A1 AR 056753A1 AR P060104784 A ARP060104784 A AR P060104784A AR P060104784 A ARP060104784 A AR P060104784A AR 056753 A1 AR056753 A1 AR 056753A1
Authority
AR
Argentina
Prior art keywords
vaccine
equine influenza
weeks
vaccination
reinforcement
Prior art date
Application number
ARP060104784A
Other languages
English (en)
Inventor
De Zande S Van
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of AR056753A1 publication Critical patent/AR056753A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacunacion de equinos contra el virus de influenza equina (EIV). Se ha descubierto que la proteccion adecuada contra la influenza equina en equinos se puede lograr cuando la vacunacion con una vacuna de influenza equina viva (primera dosis) es seguida por una vacunacion con una vacuna de influenza inactiva (refuerzo), donde las dos inyecciones se dan con una diferencia no superior a las 8 semanas entre sí. Método para vacunar animales contra la influenza equina, donde primero se vacuna un animal con una vacuna (de primera dosis), que incluye un virus de influenza equina atenuado, seguida por una vacunacion con una vacuna (de refuerzo) que incluye un virus de influenza equina inactivo, y donde la vacuna de refuerzo se administra en un período no superior a ocho semanas luego de la primera vacuna. Preferentemente las dos inyecciones se dan con un período de separacion no mayor a 8 semanas, por ejemplo, entre 3 y 6 semanas de separacion, preferentemente entre 4 y 6 semanas de separacion.
ARP060104784A 2005-11-01 2006-11-01 Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina AR056753A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05110231 2005-11-01

Publications (1)

Publication Number Publication Date
AR056753A1 true AR056753A1 (es) 2007-10-24

Family

ID=35970859

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104784A AR056753A1 (es) 2005-11-01 2006-11-01 Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina

Country Status (10)

Country Link
US (2) US7601502B2 (es)
EP (1) EP1945251B1 (es)
AR (1) AR056753A1 (es)
AT (1) ATE544469T1 (es)
AU (1) AU2006310555B2 (es)
BR (1) BRPI0618041A2 (es)
CA (1) CA2626875A1 (es)
NZ (1) NZ567684A (es)
WO (1) WO2007051763A1 (es)
ZA (1) ZA200803675B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1945251B1 (en) 2005-11-01 2012-02-08 Intervet International BV Prime boost vaccine for the protection of equines against equine influenza
KR101813017B1 (ko) 2008-08-29 2017-12-28 베링거잉겔하임베트메디카인코퍼레이티드 웨스트 나일 바이러스 백신
ES2739711T3 (es) 2010-07-22 2020-02-03 John W Schrader Anticuerpo de protección cruzada contra la infección por el virus de la gripe
CA3018230A1 (en) 2011-03-14 2012-09-20 Boehringer Ingelheim Vetmedica, Inc. Equine rhinitis b vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
EP1945251B1 (en) 2005-11-01 2012-02-08 Intervet International BV Prime boost vaccine for the protection of equines against equine influenza

Also Published As

Publication number Publication date
AU2006310555B2 (en) 2011-08-04
AU2006310555A1 (en) 2007-05-10
US7601500B2 (en) 2009-10-13
ZA200803675B (en) 2009-03-25
US7601502B2 (en) 2009-10-13
EP1945251B1 (en) 2012-02-08
ATE544469T1 (de) 2012-02-15
US20080014216A1 (en) 2008-01-17
WO2007051763A1 (en) 2007-05-10
EP1945251A1 (en) 2008-07-23
US20080292659A1 (en) 2008-11-27
BRPI0618041A2 (pt) 2011-08-16
NZ567684A (en) 2011-06-30
CA2626875A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
AR064009A1 (es) Metodo de inmunizacion contra los 4 serotipos del dengue
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
GT200200138A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
AR056566A1 (es) Vacunas y procedimientos para tratar la gripe canina
DK1881845T3 (da) Nipah-virusvacciner
CO6160335A2 (es) Vacuna
EA200970013A1 (ru) Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы
UA100370C2 (uk) Спосіб вакцинації птахів проти salmonella
CO6460752A2 (es) Respuesta inmunitaria reforzada en especies aviares
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
CO2019000214A2 (es) Vacuna contra virus de bronquitis infecciosa
PE20151588A1 (es) Vacuna contra el virus del dengue
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
AR056753A1 (es) Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina
BR112015021523A2 (pt) composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
CL2018003682A1 (es) Composición farmacéutica oral, que comprende un agente farmacéuticamente activo, al menos un polímero catiónico bioadhesivo y al menos dos polímeros aniónicos.
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CL2009000287A1 (es) Composicion que comprende un alfavirus salmonideo (sav) inactivado y al menos un componente seleccionado de una bacteria muerta/inactivada, otro virus inactivado, un hongo, un parasito y un material antigenico derivado de la bacteria, virus, hongo o parasito anterior; metodo para elaborar la composicion y uso del sav.
WO2006062637A3 (en) Influenza vaccination
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
CL2004000282A1 (es) Composicion de vacuna que comprende un nodavirus de peces inactivado, procedimiento de preparacion de la composicion, uso para la produccion de un medicamento para prevenir o tratar una infeccion por nodavirus en peces.
DE602006018985D1 (de) Zusammensetzung mit einem kolloidalen synthetischen bioresorbierbaren vektor und einem viralen vektor
AR127585A1 (es) Vacuna de arn de virus sincicial respiratorio
CU20200097A7 (es) Composición de vacuna contra la hepatitis b, proceso de obtención de dicha composición y sistema de rinovacunación para prevenir y tratar la hepatitis b

Legal Events

Date Code Title Description
FB Suspension of granting procedure